Latest News

July 6, 2017

Decibel Therapeutics Announces Investment from GV to Expand Capabilities for Biological Target Identification in Hearing Loss and Tinnitus

more

May 17, 2017

Decibel Therapeutics Opens New Headquarters and The Fenway’s First Lab

more

February 13, 2017

Decibel Therapeutics Presents at 2017 Annual Association for Research in Otolaryngology (ARO) Meeting

more

January 18, 2017

Decibel Therapeutics Expands Leadership Team With World-Class Bioinformatics Scientist; Appoints Three New Members to its Board of Directors

more

November 1, 2016

Decibel Therapeutics Assembles World-Class Scientific Advisory Board

more

September 7, 2016

Decibel Therapeutics Expands Leadership Team

more

August 4, 2016

Decibel Therapeutics to Open New Headquarters and Laboratories in The Fenway

more

July 13, 2016

Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer

more

December 16, 2015

Decibel Therapeutics Appoints Jeff Jonas, M.D., CEO of SAGE Therapeutics, to its Board of Directors

more

October 15, 2015

Third Rock Ventures Launches Decibel Therapeutics with $52 Million Series A Financing to Discover New Medicines to Protect, Repair and Restore Hearing

more